BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
43.21
+2.83 (7.01%)
At close: Jun 18, 2026
-21.68% (1Y)
| Market Cap | 18.81B -8.4% |
| Revenue (ttm) | 1.30B +9.1% |
| Net Income | 50.85M -63.2% |
| EPS | 0.12 -63.7% |
| Shares Out | 435.23M |
| PE Ratio | 369.85 |
| Forward PE | n/a |
| Dividend | 0.02 (0.04%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 17,008,570 |
| Open | 40.53 |
| Previous Close | 40.38 |
| Day's Range | 39.85 - 45.43 |
| 52-Week Range | 38.89 - 122.59 |
| Beta | 0.21 |
| Analysts | Strong Buy |
| Price Target | 38.00 (-12.06%) |
| Earnings Date | Aug 24, 2026 |